Sofinnova
Investor profile | Builders Republic
About
Sofinnova Partners is a leading European Venture Capital firm in Life Sciences, specializing in healthcare and sustainability. Based in Paris, London, and Milan, it brings together a team of professionals with strong scientific, medical, and business expertise. Unlike generalist VCs, Sofinnova operates a platform of distinct strategies (Capital, Crossover, Industrial Biotech, Digital Medicine) to cover the entire value chain of life sciences investments, from company creation to late-stage growth.
Key facts
- Type
- Venture Capital
- Stages
- Pre-Seed,Seed,Series A,Series B,Growth
- Sectors
- Life sciences,Biotech,Medtech,Digital health,Diagnostics,Healthcare
- Headquarters
- France
- Offices
- Paris,London,Milano
- Geographic focus
- France,Europe,USA
- Lead / Follow
- Lead / co-lead
- Ticket size
- 1M€ – 60M€
- Assets under management
- 4000M€
- Founded
- 1972
Track record
- Portfolio companies: 194
- Total investments: 347
- Exits: 72
Notable investments in France
Corvidia, Merus, Apellis Pharmaceuticals, Ablynx, ...
Key differentiators
Strong Track Record,Sector Specialist,Multi-stage,PE-backed